• Economy
  • Investing
  • Editor’s Pick
  • Stock
Evil Shark Trades
Economy

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

by March 25, 2025
by March 25, 2025

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump not planning to fire Waltz after national security text chain leak
next post
Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

You may also like

Trump cautioned Putin he would ‘bomb the s—‘...

I worked for the most successful third party...

Trump taps Sean Duffy to serve as interim...

Watchdog backs Rubio’s sanctions on UN official over...

Biden doctor pleads the Fifth in speedy House...

Far-left firebrand says she ‘never had a concern’...

US-backed Gaza aid group launches bold new system...

New book sheds light on Harris decision to...

Sotomayor breaks with Jackson in Supreme Court decision...

Biden doctor dodges questions in speedy House closed-door...

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Trump cautioned Putin he would ‘bomb the s—‘ out of Moscow if Russia invaded Ukraine, new book claims
    • I worked for the most successful third party in decades. Elon Musk has a lot to learn from it
    • Trump taps Sean Duffy to serve as interim NASA chief
    • Watchdog backs Rubio’s sanctions on UN official over ‘shameful efforts’ targeting US, Israel
    • Biden doctor pleads the Fifth in speedy House closed-door interview

    Categories

    • Economy (6,607)
    • Editor's Pick (3,862)
    • Investing (2,826)
    • Stock (1,369)
    Email Whitelisting About Us Terms & Conditions Privacy Policy Contact Us

    Disclaimer: Evilsharktrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 EvilSharkTrades.com


    Back To Top
    Evil Shark Trades
    • Economy
    • Investing
    • Editor’s Pick
    • Stock